Community Corner: New FDA Approval for Briviact Use in Young Children

Briviact^® CV (compund name brivaracetam)

The U.S. Food and Drug Administration (FDA) has approved the use of Briviact, from UCB, in children 4 years of age or older. Previously it was approved for people age 16 and older.

• This seizure medication is approved for use alone or with other seizure medications for the treatment of focal or partial seizures (also called focal onset seizures).
• Briviact is available in both tablet and liquid form.
• The form of Briviact for injections (given into a vein) is approved only for people age 16 and older.

The ability to use Briviact in young children will be of great benefit to children who continue to have seizures despite current therapies.

Learn more about Briviact

• More about brivaracetam
• Briviact prescribing information